Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...
This snake’s toxic bite causes paralysis, which keeps its strong and speedy eel prey from escaping. Yellow-lipped sea kraits, ...
Psoriasis is a chronic inflammatory skin disease affecting more than 60 million people worldwide, characterized by painful ...
A multidisciplinary group of experts has issued recommendations for managing systemic cancer therapies in patients undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results